Application Nr Approved Date Route Status External Links
ANDA209758 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Potassium Citrate Extended-Release Tablets Are A Citrate Salt Of Potassium Indicated For The Management Of: Renal Tubular Acidosis (Rta) With Calcium Stones ( 1.1 ) Hypocitraturic Calcium Oxalate Nephrolithiasis Of Any Etiology ( 1.2 ) Uric Acid Lithiasis With Or Without Calcium Stones ( 1.3 ) 1.1 Renal Tubular Acidosis (Rta) With Calcium Stones Potassium Citrate Is Indicated For The Management Of Renal Tubular Acidosis [See Clinical Studies ( 14.1 )]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis Of Any Etiology Potassium Citrate Is Indicated For The Management Of Hypocitraturic Calcium Oxalate Nephrolithiasis [See Clinical Studies ( 14.2 )]. 1.3 Uric Acid Lithiasis With Or Without Calcium Stones Potassium Citrate Is Indicated For The Management Of Uric Acid Lithiasis With Or Without Calcium Stones [See Clinical Studies ( 14.3 )].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Potassium Citrate POTASSIUM CITRATE ZINC895081

Comments